BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9290958)

  • 1. Codeletion of the JUN proto-oncogene and the CDKN2A tumor-suppressor gene in HRAS-transformed rat embryo fibroblast cell lines.
    Zhou JN; Ljungdahl S; Röhme D; Levan G; Shoshan MC; Linder S
    Genes Chromosomes Cancer; 1997 Sep; 20(1):82-9. PubMed ID: 9290958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun.
    Marshall-Heyman H; Engel G; Ljungdahl S; Shoshan MC; Svensson C; Wasylyk B; Linder S
    Oncogene; 1994 Dec; 9(12):3655-63. PubMed ID: 7970724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts.
    Marshall H; Popowicz P; Engel G; Martens I; Linder S
    Oncogene; 1993 May; 8(5):1303-9. PubMed ID: 8479751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.
    Bloethner S; Hemminki K; Thirumaran RK; Chen B; Mueller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
    Melanoma Res; 2006 Aug; 16(4):297-307. PubMed ID: 16845325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts.
    Obata M; Lee GH; Kanda H; Kitagawa T; Ogawa K
    Mol Carcinog; 1997 May; 19(1):17-24. PubMed ID: 9180924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
    Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
    Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
    Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
    Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mechanisms and frequency of CDKN2A/B gene loss during progression of RAS-transformed rat embryo fibroblast clones.
    Zhou JN; Hashemi J; Helou K; Zhang A; Röhme D; Zetterberg A; Levan G; Linder S
    Somat Cell Mol Genet; 1998 Nov; 24(6):327-39. PubMed ID: 10763411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
    Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
    Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
    Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK1-dependent autocrine loop.
    Ljungdahl S; Linder S; Franzén B; Binétruy B; Auer G; Shoshan MC
    Cell Growth Differ; 1998 Jul; 9(7):565-73. PubMed ID: 9690624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M; Pollock PM; Walters MK; Sparrow LE; Down LM; Gabrielli BG; Parsons PG; Hayward NK
    Cancer Res; 1997 Nov; 57(21):4868-75. PubMed ID: 9354451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
    Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
    Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
    Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.